IMMUNOVANT INC. - CO
29,40
07-октября-24 14:59:58
15 мин. задержка
Акции
-1,11
-3,64%
Сегодняшний диапазон
28,92 - 30,58
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Immunovant Announces Pricing of $75.0 Million Underwritten Offering of Common Stock
04 окт 2022 07:45:00 Источник Nasdaq GlobeNewswire
-
Immunovant Announces IMVT-1402, a Next Generation Anti-FcRn
28 сен 2022 09:45:00 Источник Nasdaq GlobeNewswire
-
Immunovant to Present at Roivant Investor Day on September 28th
21 сен 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
09 сен 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
UPDATE -- Immunovant Announces Two New Development Programs for Batoclimab
07 сен 2022 06:11:44 Источник Nasdaq GlobeNewswire
-
Immunovant Announces Two New Development Programs for Batoclimab
07 сен 2022 05:30:00 Источник Nasdaq GlobeNewswire
-
24 авг 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
Immunovant Reports Financial Results and Recent Business Updates for the Quarter Ended June 30, 2022
05 авг 2022 06:00:00 Источник Nasdaq GlobeNewswire
-
08 июн 2022 06:00:01 Источник Nasdaq GlobeNewswire
-
Immunovant to Report Fourth Quarter and Full Year 2022 Financial Results on June 8, 2022
06 июн 2022 15:47:47 Источник Nasdaq GlobeNewswire
-
Immunovant to Present at the H.C. Wainwright Global Investment Conference on May 25th
23 май 2022 15:05:00 Источник Nasdaq GlobeNewswire
-
Immunovant to Present at the UBS Global Healthcare Conference on May 23rd
19 май 2022 15:05:00 Источник Nasdaq GlobeNewswire
-
Immunovant to Present at LifeSci Partners’ Immunology and Inflammation Symposium on May 10th
04 май 2022 07:00:02 Источник Nasdaq GlobeNewswire
-
Immunovant to Host Virtual R&D Day on March 30, 2022
28 мар 2022 06:00:00 Источник Nasdaq GlobeNewswire
-
Immunovant to Present at the 11th Annual SVB Leerink Global Healthcare Conference
09 фев 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
Immunovant Reports Financial Results for the Quarter Ended December 31, 2021
04 фев 2022 06:00:00 Источник Nasdaq GlobeNewswire
-
Immunovant Appoints Mark Levine as Chief Legal Officer
25 янв 2022 07:30:00 Источник Nasdaq GlobeNewswire
-
Immunovant to Present at the 40th Annual J.P. Morgan Healthcare Conference
07 янв 2022 13:07:31 Источник Nasdaq GlobeNewswire
-
30 дек 2021 06:00:00 Источник Nasdaq GlobeNewswire
-
Immunovant to Present at the Stifel 2021 Virtual Healthcare Conference
12 ноя 2021 11:18:05 Источник Nasdaq GlobeNewswire